Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

How To Take A quiz?

Fill out all required information.
Carefully read the question.
Then choose the answer and click on it.
Correct/Incorrect response will be displayed.
Use "Next" button to go to the next question.
Score will be shown at the conclusion of the quiz.
Received Passing score - Great ! close the browser window
Received Failed score - Retake quiz until you pass

Ready? Let's click on "Start Quiz" button and get started !

Please enter Full Legal Name (First and Last Name) to be printed on the certificate.

1 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 1 :

A patient having been prescribed opioids by a previous provider is not, in and of itself, a reason to continue opioids.

A) True

B) False

2 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 2 :

Chronic non-malignant pain shall not be treated using controlled substances through telemedicine.

A) True

B) False

3 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 3 :

Treatment plans should set treatment goals with all patients, including realistic goals for pain and function. One commonly used assessment is the 3-item PEG Assessment Scale, which includes all, EXCEPT:

A) Pain average

B) Eliminate pain

C) Interference with Enjoyment of Life

D) Interference with General Activity

4 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 4 :

When starting opioid therapy as a provider for chronic pain, clinicians should generally prescribe _________________.

A) Immediate-release opioids

B) Extended-release

C) Long-acting opioids

D) None of the above

5 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 5 :

No provider is obligated to continue opioid therapy that another provider has initiated.

A) True

B) False

6 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 6 :

Providers must continually monitor the patient for signs of abuse, misuse, or diversion. An unannounced UDT (or a comparable oral fluids test) should be done at least every ________.

A) 2 months

B) 3 months

C) 4 months

D) 6 months

7 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 7 :

Patients on opioid doses of _________ or greater should be referred to a pain specialist for a consultation and/or management.

A) 40mg MEDD

B) 60mg MEDD

C) 120mg MEDD

D) All of the above

8 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 8 :

A history of alcoholism or drug misuse, abuse, addiction, diversion, dependency, tolerance, or hyperalgesia is considered _________ for developing problematic opioid behaviors.

A) Low Risk

B) Medium Risk

C) High Risk

D) No Risk

9 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 9 :

Data-informed guidance indicates that the risk of overdose death begins at 40 MEDD for opioid-naïve patients. The risk increases tenfold above 81 MEDD for all patients.

A) True

B) False

10 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 10 :

Tennessee law mandates that healthcare prescribers offer naloxone to patients under specific conditions:

A) When the provider prescribes more than a three-day supply of an opioid

B) When the provider prescribes an opioid concurrently with a benzodiazepine

C) When the patient has an increased risk for overdose

D) All of the above

11 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 11 :

Signs and symptoms that, if present, may indicate a problematic response to the opioid and interference with the goal of functional improvement include all EXCEPT:

A) Excessive sleeping or days and nights turned around

B) Increased appetite

C) Short attention span or inability to concentrate

D) Mood volatility, especially irritability

12 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 12 :

Required information submitted to the Tennessee Controlled Substance Monitoring Database (CSMD) includes:

A) Patient identifier

B) The prescriber’s DEA number and Controlled Substances National Drug Code number

C) Dispensing date, number, quantity dispensed, strength, estimated day supply, and the dispenser’s DEA number

D) All of the above

13 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 13 :

Before an initial low-dose opioid prescription is provided, written informed consent or "treatment agreement" is NOT required to obtain.

A) True

B) False

14 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 14 :

Benzodiazepines should generally be avoided in combination with chronic opioid therapy

A) True

B) False

15 / 15

Controlled Substance Prescribing - The Tennessee Chronic Pain Guidelines

Question 15 :

Reasons to taper or stop an opioid regimen include:

A) Inadequate pain relief

B) Significant misuse of medication, and Lack of improvement in the quality of life despite adjusting the dosage

C) Deteriorating function

D) All of the above

Your score is

Our Course Categories

Unlimited CEUs

Infection Control

Dental

Nursing

Pharmacy

Physical Therapy

Occupational Therapy

Massage Therapy

Rehab CE (🎥+PDF)

SLP & Audiology

Pharmacology CE

LCSWs/MFTs/LMHCs

Compliance

Tattoo/Body Art BBP

HIPAA Training

Biologix Solutions LLC